Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
W. Mark Watson currently holds 78,700 shares of HedgePath Pharmaceuticals, Inc. (HPPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, W. Mark Watson has been a net seller of HPPI stock. They have purchased $42.4K and sold $145.6K worth of shares.
W. Mark Watson's most recent insider trade was on Jul 16, 2026, when they sold 78,700 shares at $0.00 per share.
W. Mark Watson serves as Executive at HedgePath Pharmaceuticals, Inc. (HPPI). They have executed 53 insider transactions totaling $188.1K over their tenure at the company.
W. Mark Watson holds the position of Executive at HedgePath Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
W. Mark Watson has shown a selling trading pattern, with $42.4K in total purchases and $145.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by W. Mark Watson was on Mar 30, 2020, when they sold $78.3K worth of SYKE shares. This transaction involved 3,000 shares at $26.10 per share.
W. Mark Watson currently owns 78,700 shares of HedgePath Pharmaceuticals, Inc. (HPPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of W. Mark Watson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. W. Mark Watson has 53 Form 4 filings on record as an insider at HedgePath Pharmaceuticals, Inc..
Set alerts for W. Mark Watson and 40,000+ other insiders.